Puzniak, Laura

Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

Raman, G., Avendano, E. E., Chan, J., Merchant, S., & Puzniak, L. (2018) · Antimicrobial Resistance & Infection Control

Antibiotic Resistance in BacteriaBacterial biofilms and quorum sensing

Cited by 269

Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe

Wiemken, T. L., Khan, F., Puzniak, L., Yang, W., Simmering, J., Polgreen, P., Nguyen, J. L., Jodar, L., & McLaughlin, J. M. (2023) · Scientific Reports

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 138

BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5

Tartof, S. Y., Slezak, J. M., Puzniak, L., Hong, V., Frankland, T. B., Ackerson, B. K., Takhar, H., Ogun, O. A., Simmons, S., Zamparo, J. M., et al. (2022) · The Lancet Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 66

Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study

Tartof, S. Y., Slezak, J. M., Puzniak, L., Hong, V., Frankland, T. B., Xie, F., Ackerson, B. K., Valluri, S. R., Jodar, L., & McLaughlin, J. M. (2023) · The Lancet Respiratory Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 36